Acrivon Therapeutics, Inc.
corporate_fare Company Profile
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ACRV at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Acrivon Therapeutics Reports Strong Clinical Data for ACR-368 in Endometrial Cancer and Promising ACR-2316 Phase 1 Results
- Acrivon Therapeutics Reports Strong Cash Position and Positive Clinical Data Across Multiple Programs
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$77.91M
Diluted EPS
-$2.02
Op. Cash Flow
-$63.66M
Free Cash Flow
-$65.33M
Operating Income
-$84.11M
Cash & Equivalents
$41.5M
Debt / Equity
0.00×
Shares Outstanding
31.65M sh
Source: 10-K · filed 2026-03-19 · accession 0001193125-26-115123
show_chartPrice Chart
Loading chart...